[c09aa8]: / clusters / clustall9k / 576.txt

Download this file

81 lines (80 with data), 12.2 kB

 1
 2
 3
 4
 5
 6
 7
 8
 9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
61
62
63
64
65
66
67
68
69
70
71
72
73
74
75
76
77
78
79
80
Involvement in the planning and/or conduct of the study (applies to both AstraZeneca staff and/or staff at the study site)
Involvement in the planning and/or conduct of the study
Involvement in the planning and/or conduct of the study (applies to both AstraZeneca staff and/or staff at the study site)
Involvement in the planning and/or conduct of the study
Participants who are involved in the planning and/or conduct of the study (applies to both AstraZeneca staff and/or staff at the study site)
Participants with involvement in the planning and/or conduct of the study (applies to both AstraZeneca staff and/or staff at the study site)
Involvement in study planning and conduct (i.e., Hansoh staff or staff at the study site).
Involvement in the planning and/or conduct of the study (applies to both AstraZeneca staff and/or staff at the study site); previous enrollment in the present study
Involvement in the planning and/or conduct of the study (applies to both AstraZeneca staff and/or staff at the study site).
Involvement in the planning and/or conduct of the study (applies to both investigator staff and/or staff at the study site)
Involvement in the planning and/or conduct of the study (applies to AstraZeneca and/or Sarah Cannon Development Innovations staff and/or staff at the study site).
Involvement in the planning and/or conduct of the study (applies to both AstraZeneca staff and/or staff at the study site)
Involvement in the planning and/or conduct of the study (applies to both AstraZeneca staff and/or staff at the study site)
Involvement in the planning and/or conduct of the study (applies to both AstraZeneca staff and/or staff at MD Anderson).
Involvement in the planning and/or conduct of the study
Involvement in the planning and/or conduct of the study (applies to both AstraZeneca staff and/or staff at the study site), previous enrollment in the present study.
Involvement in the planning and/or conduct of the study (applies to staff at the study site) or previous enrollment in the present study
Involvement in the planning and/or conduct of the study (applies to both AstraZeneca staff and/or staff at the study site)
Involvement in the planning and/or conduct of the study in the present study
Involvement in the planning and/or conduct of the study (applies to both AstraZeneca staff and/or staff at the study site)
Involvement in the planning and/or conduct of the study (applies to both AstraZeneca staff and/or staff at the study site)
Involvement in the planning and/or conduct of the study (applies to both AstraZeneca staff and/or staff at the study site)
Involvement in the planning and/or conduct of the study (applies to both AstraZeneca staff and/or staff at the study site)
Involvement in the planning and/or conduct of the study (applies to both AstraZeneca staff and/or staff at the study site).
Involvement in the planning and/or conduct of the study
Involvement in the planning and/or conduct of the study (applies to AstraZeneca staff and/or staff at the study site)
Involvement in the planning and/or conduct of the study (applies to both AstraZeneca staff and/or staff at the study site) or previous enrollment in the present study
Involvement in the planning and/or conduct of the study (applies to both AstraZeneca staff and/or staff at the study site); previous enrollment in the present study
Involvement in the planning and/or conduct of the study (applies to both AstraZeneca staff and/or staff at the study site) or previous enrollment in the present study
Involvement in the planning and/or conduct of the study (applies to both AstraZeneca staff and/or staff at the study site); previous enrollment in the present study
Involvement in the planning and/or conduct of the study (applies to both AstraZeneca staff and/or staff at the study site); previous enrolment in the present study
Involvement in the planning and/or conduct of the study (applies to both AstraZeneca staff and/or staff at the study site); previous enrolment or randomization in the present study
Involvement in the planning and/or conduct of the study (applies to both AstraZeneca staff and/or staff at the study site)
Involvement in the planning and/or conduct of the study (applies to both AstraZeneca staff and/or staff at the study site)
Involvement in the planning and/or conduct of the study (applies to both AstraZeneca staff and/or staff at the study site)
Involvement in the planning and/or conduct of the study (applies to both AstraZeneca staff and/or staff at the study site); previous enrollment or randomization in the present study
Patients who are involved in the planning and/or conduct of the study (applies to both AstraZeneca staff and/or staff at the study site); previous enrollment or randomization in the present study
Involvement in the planning and/or conduct of the study (applies to both AstraZeneca staff and/or staff at the study site).
safety of study staff
Involvement in the planning and/or conduct of the study (applies to both AstraZeneca staff and/or staff at the study site)
Involvement in the planning and/or conduct of the study
Involvement in the planning and/or conduct of the study
Involvement in the planning and/or conduct of the study (applies to both AstraZeneca staff and/or staff at the study site); previous enrollment in the present study
Involvement in the planning and/or conduct of the study (applies to both AstraZeneca staff and staff at University of Iowa Hospitals and Clinics [UIHC])
Involvement in the planning and/or conduct of the study (applies to both AstraZeneca staff and/or staff at the study site)
safety of study staff
Involvement in the planning and/or conduct of the study (applies to both AstraZeneca staff and/or staff at the study site).
Involvement in the planning and/or conduct of the study (applies to both AstraZeneca, contract research organization [CRO] staff, and/or staff at the central processing unit [CPU])
Involvement in the planning and/or conduct of the study (applies to both AstraZeneca staff and/or staff at the study site); previous enrollment in the present study
Involvement in the planning and/or conduct of the study
Involvement in the planning and/or conduct of the study
Involvement in the planning and/or conduct of the study (applies to both AstraZeneca staff, its agents and/or staff at the study site).
Involvement in the planning and/or conduct of the study (applies to both AstraZeneca staff and/or staff at the study site).
safety of study staff
Involvement in the planning and/or conduct of the study (applies to both AstraZeneca staff and/or staff at the study site).
Involvement in the planning and/or conduct of the study (applies to both AstraZeneca staff and/or staff at the study site)
Involvement in the planning and/or conduct of the study (applied to both AstraZeneca staff and/or staff at the study site); previous enrollment in the previous study
Involvement in the planning and/or conduct of the study (applies to both AstraZeneca Representative staff and/or staff at the study site);
Involvement in the planning and/or conduct of the study (applies to both AstraZeneca staff and/or staff at the study site)
Involvement in the planning and/or conduct of the study (applies to both AstraZeneca staff and/or staff at the study site)
Patient is a staff member of the sponsor or clinical site and is involved in the conduct of the study or the relative of such a staff member. Patient Exclusion Criteria - Part 2:
Patient is a staff member of the sponsor or clinical site and is involved in the conduct of the study or the relative of such a staff member
Involvement in the planning and/or conduct of the study (applies to both AstraZeneca staff and/or staff at the study site)
Involvement in the planning and/or conduct of the study (applies to both AstraZeneca staff and/or staff at the study site)
Involvement in the planning and conduct of the study (applies to both Astra Zeneca staff and staff at the study site)
Involvement in the planning and/or conduct of the study (applies to both AstraZeneca, Contract Research Organization [CRO] staff, and/or staff at the CPU)
Is or has an immediate family member (e.g., spouse, parent/legal guardian, sibling or child) who is investigational site or sponsor staff directly involved with this trial, unless prospective Institutional Review Board (IRB) approval (by chair or designee) is given allowing exception to this criterion for a specific subject
Is or has an immediate family member (e.g., spouse, parent/legal guardian, sibling, or child) who is investigational site or sponsor staff directly involved with this trial, unless prospective Institutional Review Board (IRB) approval (by chair or designee) is given allowing exception to this criterion for a specific subject
Subjects must not be or have an immediate family member (spouse, parent, legal guardian, sibling or child) who is an investigational site sponsor or staff directly involved with the trial, unless IRB approval is granted previously
Is or has an immediate family member (e.g., spouse, parent/legal guardian, sibling or child) who is investigational site or sponsor-investigator staff directly involved with this trial, unless prospective Institutional Review Board [IRB] approval (by chair or designee) is given allowing exception to this criterion for a specific subject
Is or has an immediate family member (example, spouse, parent/legal guardian, sibling or child) who is investigational site or sponsor staff directly involved with this trial, unless prospective Institutional Review Board (IRB) approval (by chair or designee) is given allowing exception to this criterion for a specific subject.
Is or has an immediate family member (spouse or children) who is investigational site or staff directly involved with this trial, unless prospective Institutional Review Board (IRB) approval (by chair or designee) is given allowing exception to this criterion for a specific subject
Participant is or has an immediate family member (e.g., spouse, parent/legal guardian, sibling or child) who is an investigational site or sponsor-investigator staff directly involved with this trial, unless prospective IRB approval (by chair or designee) is granted allowing exception to this criterion for a specific subject
Is or has an immediate family member (spouse or children) who is investigational site or sponsor staff directly involved with this study, unless prospective institutional review board (IRB) approval (by chair or designee) is given allowing exception to this criterion for a specific subject
Immediate family member who is investigational site or sponsor staff directly involved with this study
Participant is or has an immediate family member (spouse or children) who is investigational site or sponsor staff directly involved with this trial, unless prospective Institutional Review Board (IRB) approval (by chair or designee) is given allowing exception to this criterion for a specific participant.
Patient is or has an immediate family member (e.g., spouse, parent/legal guardian, sibling or child) who is investigational site or Sponsor staff directly involved with this trial without prospective Institutional Review Board approval (by chair or designee) is given
Is or has an immediate family member (e.g., spouse, parent/legal guardian, sibling or child) who is investigational site or sponsor staff directly involved with this trial.
Is or has an immediate family member who is investigational site or sponsor staff directly involved with this study
History or current evidence of any condition, therapy, or laboratory abnormality that might confound the results of the trial, interfere with the subject's participation for the full duration of the trial, or is not in the best interest of the subject to participate, in the opinion of the treating Investigator. Is or has an immediate family member (e.g. spouse, parent/legal guardian, sibling or child) who is investigational site or sponsor staff directly involved with this trial, unless prospective Institutional Review Board (IRB) approval (by chair or designee) is given allowing exception to this criterion for a specific subject.